期刊文献+

2型糖尿病大血管病变患者血清基质金属蛋白酶9及其抑制物1的测定 被引量:3

Measure serum metalloproteinase matrix-9 and tissue inhibitor of metalloproteinase-1 in the patients with type 2 diabetic macroangiopathy
暂未订购
导出
摘要 目的:探讨血清MMP-9及TIMP-1水平与糖尿病大血管病变的关系。方法:采用酶联免疫吸附法对30例正常对照者和54例2型糖尿病患者(其中无合并症糖尿病组29例,合并大血管并发症组25例)血清MMP-9及TIMP-1水平进行检测,分析其与大血管病变的关系。结果:2型DM血清MMP-9、TIMP-1水平与对照组比较显著升高,且随着大血管病变程度呈逐步升高趋势,MMP-9与FBG呈显著正相关(r=0.444,P<0.05),TIMP-1与UAER呈正相关(r=0.395,P<0.05)。结论:认为MMP-9、TIMP-1参与DM大血管病变的发生发展,检测其血清水平可反映DM血管病变的严重程度。 Objective To measure the serum metalloproteinase matrix-9(MMP-9) and tissue inhibitor of metalloproteinase-1(TIMP-1) levels,and explore the significance of them in the pathogenesis of type 2 diabetic macroangiopathy.Methods The levels of serum MMP-9 and TIMP-1 were measured by ELISA in 30 normal control group and 54 cases with type 2 diabetic mellitus including 29 cases without complications and 25 cases with macroangiopathy.Results The levels of MMP-9 and TIMP-1 were markedly elevated in diabetic macroangiopathy group than in normal control group (P< 0.05),There were remarkably positive correlations between MMP-9 and FBG,LDL-C,while TIMP-1 was correlated positively with UAER.Conclusion The MMP-9 and TIMP-1 are critically involved in the development of type 2 diabetic macroangiopathy,and the increased serum MMP-9 and TIMP-1 levels in DM patients are related to the severity of diabetic macroangiopathy.
出处 《实用医学杂志》 CAS 2005年第9期896-897,共2页 The Journal of Practical Medicine
关键词 2型糖尿病 大血管病变 血清基质金属蛋白酶9 抑制物1 测定 Matrix metalloproteinases Diabetic mellitus,type Ⅱ
  • 相关文献

参考文献5

二级参考文献8

  • 1Zhang BP, Ye S, Herrmann SM, et al. Functional polymorphism in the regulatory region of gelatinase B gen in relation to severity of coronary atherosclerosis. Circulation, 1999,99:1788-1794.
  • 2Bennett MR. Apoptosis of vascular smooth muscle cells in vascular remodelling and atheroslerotic plaque rupture. Cardiovasc-Res, 1999,41 :361-368.
  • 3Rekhter MD, Hicks GW, Brammer DW, et al. Hypercholesterolemia causes mechanical weakening of rabbit atheroma: local collagen loss as a prerequisite of plaque rupture. Cire-Res ,2000,86 : 101-108.
  • 4Xu XP, Meisel SR, Ong JM, et al. Oxidized low-density lipoprotein regulates matrix metalliproteianse-9 and its tissue inhibitor in human monocyte-derived macrophage. Circulation, 1999 24:993-998.
  • 5Mach F, Schonbeck U,Bonnefoy JY, et al. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40. Circulation, 1997,96:396-399.
  • 6Suzuki D;Miyazaki M;Jinde K.In situ hybridization studies of matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-1 and type Ⅳ collagen in diabetic nephropathy[J],1997(1).
  • 7Ebihara I;Nakamura T;Shimada N.Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus,1998.
  • 8Kanauchi M;Nishioka H;Nakashiam Y.Role of tissue inhibitors of metalloproteinase in diabetic nephropathy,1996(03).

共引文献49

同被引文献22

  • 1陈兴雅,沈庆乐,张存琪.血清基质金属蛋白酶与糖尿病血管病变的关系[J].中国误诊学杂志,2005,5(2):248-249. 被引量:4
  • 2周一军,张锦,李莉,彭扬.糖尿病患者动脉粥样硬化斑块内基质金属蛋白酶2和9与斑块稳定的关系[J].中国动脉硬化杂志,2005,13(1):69-72. 被引量:10
  • 3吕雪欣.糖代谢紊乱中的细胞因子[J].继续医学教育,2005,19(4):44-48. 被引量:1
  • 4Zaltsnmn AB,Newby AC.Increased secretion of gelatinases A and B from the aortas of cholesterol fed rabbits:relationship to lesion severity.Athemsclerosis,1997,130:61-70.
  • 5Hisashi Kai,Hisao Ikoda,Hideo Yasukawa,et al.Peripheral blood levels of matrix metalloproteinase-9 and-2 are elevated in patients with acrute coronary syndromes[J].J Am Coll Cardial,1998,32(2):368-372.
  • 6Zhang B,Ye S,Herrmann SM,et al.Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis.Circulation,1999,99:1788-1794.
  • 7Mason DP,Kenagy RD,Hasenstab D,et al.Matrix metalloproteinase-9 overexpression enhanees vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery.Cire Res,1999,85:1179-1185.
  • 8Mclennan S,Fisher E,Martell S Y,et al.Effects of glucose on matrix metalloproteinase and plaem in activities in mesangial cells:possible role in diabetic nephropathy[J].Kideny Int,2000,58(Suppl77):s81.
  • 9Mignatti P.Extracellular matrix remodeling by metalloproteinases and plasm inogen activators[J].Kidney,1995,47 (Supp149):s12.
  • 10Visse R,Nagase H.Matrix metalloproteinnase and tissue in hibitors of metalloproteinase:structure,function,and biochemistry[J].Circ Res,2003,92:827.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部